AI Medical Compendium Topic

Explore the latest research on artificial intelligence and machine learning in medicine.

Pancreatic Neoplasms

Showing 41 to 50 of 342 articles

Clear Filters

Diagnosis of Pancreatic Ductal Adenocarcinoma Using Deep Learning.

Sensors (Basel, Switzerland)
Recent advances in artificial intelligence (AI) research, particularly in image processing technologies, have shown promising applications across various domains, including health care. There is a significant effort to use AI for the early diagnosis ...

Construction of a combined prognostic model for pancreatic ductal adenocarcinoma based on deep learning and digital pathology images.

BMC gastroenterology
BACKGROUND: Deep learning has made significant advancements in the field of digital pathology, and the integration of multiple models has further improved accuracy. In this study, we aimed to construct a combined prognostic model using deep learning-...

Antigen-independent single-cell circulating tumor cell detection using deep-learning-assisted biolasers.

Biosensors & bioelectronics
Circulating tumor cells (CTCs) in the bloodstream are important biomarkers for clinical prognosis of cancers. Current CTC identification methods are based on immuno-labeling, which depends on the differential expression of specific antigens between t...

Predicting and Monitoring Immune Checkpoint Inhibitor Therapy Using Artificial Intelligence in Pancreatic Cancer.

International journal of molecular sciences
Pancreatic cancer remains one of the most lethal cancers, primarily due to its late diagnosis and limited treatment options. This review examines the challenges and potential of using immunotherapy to treat pancreatic cancer, highlighting the role of...

Advancing frontline early pancreatic cancer detection using within-class feature extraction in FTIR spectroscopy.

Scientific reports
This study introduces a novel approach for the early detection of pancreatic cancer through biofluid spectroscopy, leveraging a unique machine learning pipeline comprising class-specific principal component analysis (PCA), linear discriminant analysi...

Prediction of 12-month recurrence of pancreatic cancer using machine learning and prognostic factors.

BMC medical informatics and decision making
BACKGROUND AND AIM: Pancreatic cancer is lethal and prevalent among other cancer types. The recurrence of this tumor is high, especially in patients who did not receive adjuvant therapies. Early prediction of PC recurrence has a significant role in e...

Enhancing detection of various pancreatic lesions on endoscopic ultrasound through artificial intelligence: a basis for computer-aided detection systems.

Journal of gastroenterology and hepatology
BACKGROUND AND AIM: Endoscopic ultrasound (EUS) is the most sensitive method for evaluation of pancreatic lesions but is limited by significant operator dependency. Artificial intelligence (AI), in the form of computer-aided detection (CADe) systems,...

Predicting Pancreatic Cancer in New-Onset Diabetes Cohort Using a Novel Model With Integrated Clinical and Genetic Indicators: A Large-Scale Prospective Cohort Study.

Cancer medicine
INTRODUCTION: Individuals who develop new-onset diabetes have been identified as a high-risk cohort for pancreatic cancer (PC), exhibiting an incidence rate nearly 8 times higher than the general population. Hence, the targeted screening of this spec...

Assessing Large Language Models for Oncology Data Inference From Radiology Reports.

JCO clinical cancer informatics
PURPOSE: We examined the effectiveness of proprietary and open large language models (LLMs) in detecting disease presence, location, and treatment response in pancreatic cancer from radiology reports.

Explainable machine learning identifies a polygenic risk score as a key predictor of pancreatic cancer risk in the UK Biobank.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
BACKGROUND: Predicting the risk of developing pancreatic ductal adenocarcinoma (PDAC) is of paramount importance, given its high mortality rate. Current PDAC risk prediction models rely on a limited number of variables, do not include genetics, and h...